Our AI-driven platform proves that precision medicine can develop safer, more effective therapies by understanding cellular mechanisms at the molecular level. Read the full study: cell.com/cell-stem-cell… #DrugDiscovery #Biotechnology #Innovation #PrecisionMedicine

❄️ Happy Holidays from all of us at Greenstone Biosciences! ❄️ As we wrap up another year, we want to extend our warmest wishes to our incredible collaborators, partners, and supporters. May this winter season bring you joy, rest, and renewed energy. #HappyHolidays

This is one of the best meetings in #DrugDiscovery organized by co-founder Joseph C Wu, MD, PhD. Greenstone Biosciences is proud to be a sponsor of #SDDS2025. Looking forward to an exciting 2-day event of discussion among pharma, biotech, FDA, VC, and academia thought leaders.

Revolutionize drug discovery with NAMs! 💡 Join Greenstone Biosciences's FREE webinar on using patient iPSCs to boost efficacy, safety & translation. 📅 June 24 | ⏰ 10 AM PDT 🔗 Register: us06web.zoom.us/webinar/regist… #DrugDiscovery #iPSC #NAM #FDA #Biotech #Organoids #PreclinicalResearch

I am honored to receive this year's McGill Heart and Stroke Lucian Award for excellence in cardiovascular research. Special thanks to Rhian Touyz, Terry Herbert, Celine Fiset, and other committee members. mcgill.ca/lucianaward/ Stanford Medicine Stanford CVI Stanford Department of Medicine Sarafan ChEM-H

CKM syndrome reflects complex heart-kidney-metabolic interactions. A new Circulation Research review co-authored by Greenstone cofounder Dr. Joe Wu explores how organ-on-chip models can replicate interorgan crosstalk and accelerate translational research. ahajournals.org/doi/10.1161/CI…

We're pleased to see our work on vascularized cardiac & liver organoids published in Science Magazine. Congrats to Oscar J. Abilez Huaxiao 'Adam' Yang and co-authors. Stanford CVI Stanford Medicine Stanford Department of Medicine Sarafan ChEM-H Greenstone Biosciences …bi-nlm-nih-gov.laneproxy.stanford.edu/40472086/ med.stanford.edu/news/all-news/…

Headed to #ISSCR2025? Catch Dr. Paul Pang from Greenstone Biosciences presenting “Clinical Trial in a Dish with iPSCs for Drug Discovery & Precision Medicine” on Thurs, June 12 at 8:30 AM HKT. Visit booth 5\_SUP to connect! 🔗 isscr2025.org #iPSC #Biotech #DrugDiscovery

One day left ⏰ Join Greenstone Biosciences tomorrow for a live webinar on how patient iPSCs + organoids are transforming drug discovery, aligned with the FDA Modernization Act 3.0. 📅 June 24 | 🕙 10 AM PDT Register: [us06web.zoom.us/webinar/regist…] #NAMs #DrugDiscovery #hiPSCs #Organoids

Missed our webinar on NAMs + patient iPSCs? The full recording is now live.🎥 Watch here: [youtu.be/bmgIAVGPlH8] Thanks to everyone who joined us live and made it a great session! #NAMs #DrugDiscovery #hiPSCs #Organoids #Webinar #FDAModernization

Headed to the American Heart Association's Basic Cardiovascular Sciences (BCVS) 2025 meeting? Come connect with Greenstone Biosciences in Baltimore, Maryland, from July 23–26, 2025! #BCVS2025 #AHA #CardiovascularResearch #StemCells #hiPSC #Biobank #GreenstoneBiosciences

Sept 2 @ 10 AM PDT/1 PM EDT – Learn how #hiPSC #Cardiomyocyte #NAMs go beyond hERG for pre-clinical cardiac safety screening, enabling faster, more human-relevant drug discovery. 🔗 Register: (us06web.zoom.us/webinar/regist…) #DrugDiscovery #FDA #Toxicology #StemCells #NAMs

We’re excited to welcome Dr. Angelos Oikonomopoulos to Greenstone Biosciences as our newest Senior Scientist! He brings expertise in cardiac biology, regenerative medicine, and translational research. Read more about his work here ⬇️ linkedin.com/posts/greensto…